Skip to main content

and
  1. Article

    Open Access

    Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis

    The aim of this study was to evaluate guselkumab efficacy on regional psoriasis in a subset of psoriasis patients with a self-reported psoriatic arthritis (PsA) diagnosis.

    Ana-Maria Orbai, Soumya D. Chakravarty, Yin You, May Shawi in Dermatology and Therapy (2023)

  2. No Access

    Article

    Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study

    Guselkumab effectively treats moderate-to-severe psoriasis.

    Kristian Reich, April W. Armstrong, Peter Foley in American Journal of Clinical Dermatology (2020)

  3. Article

    Open Access

    Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

    Health-related quality of life (HRQoL) may be markedly impaired in patients with moderate-to-severe psoriasis.

    April W. Armstrong, Kristian Reich, Peter Foley in American Journal of Clinical Dermatology (2019)